These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
282 related articles for article (PubMed ID: 22060274)
1. ARTEMIN synergizes with TWIST1 to promote metastasis and poor survival outcome in patients with ER negative mammary carcinoma. Banerjee A; Wu ZS; Qian P; Kang J; Pandey V; Liu DX; Zhu T; Lobie PE Breast Cancer Res; 2011; 13(6):R112. PubMed ID: 22060274 [TBL] [Abstract][Full Text] [Related]
2. ARTEMIN promotes de novo angiogenesis in ER negative mammary carcinoma through activation of TWIST1-VEGF-A signalling. Banerjee A; Wu ZS; Qian PX; Kang J; Liu DX; Zhu T; Lobie PE PLoS One; 2012; 7(11):e50098. PubMed ID: 23185544 [TBL] [Abstract][Full Text] [Related]
3. Artemin stimulates radio- and chemo-resistance by promoting TWIST1-BCL-2-dependent cancer stem cell-like behavior in mammary carcinoma cells. Banerjee A; Qian P; Wu ZS; Ren X; Steiner M; Bougen NM; Liu S; Liu DX; Zhu T; Lobie PE J Biol Chem; 2012 Dec; 287(51):42502-15. PubMed ID: 23095743 [TBL] [Abstract][Full Text] [Related]
4. Artemin is estrogen regulated and mediates antiestrogen resistance in mammary carcinoma. Kang J; Qian PX; Pandey V; Perry JK; Miller LD; Liu ET; Zhu T; Liu DX; Lobie PE Oncogene; 2010 Jun; 29(22):3228-40. PubMed ID: 20305694 [TBL] [Abstract][Full Text] [Related]
5. Trefoil factor 3 promotes metastatic seeding and predicts poor survival outcome of patients with mammary carcinoma. Pandey V; Wu ZS; Zhang M; Li R; Zhang J; Zhu T; Lobie PE Breast Cancer Res; 2014 Sep; 16(5):429. PubMed ID: 25266665 [TBL] [Abstract][Full Text] [Related]
6. Tamoxifen inhibits ER-negative breast cancer cell invasion and metastasis by accelerating Twist1 degradation. Ma G; He J; Yu Y; Xu Y; Yu X; Martinez J; Lonard DM; Xu J Int J Biol Sci; 2015; 11(5):618-28. PubMed ID: 25892968 [TBL] [Abstract][Full Text] [Related]
7. High TWIST1 mRNA expression is associated with poor prognosis in lymph node-negative and estrogen receptor-positive human breast cancer and is co-expressed with stromal as well as ECM related genes. Riaz M; Sieuwerts AM; Look MP; Timmermans MA; Smid M; Foekens JA; Martens JW Breast Cancer Res; 2012 Sep; 14(5):R123. PubMed ID: 22967435 [TBL] [Abstract][Full Text] [Related]
8. Artemin-stimulated progression of human non-small cell lung carcinoma is mediated by BCL2. Tang JZ; Kong XJ; Kang J; Fielder GC; Steiner M; Perry JK; Wu ZS; Yin Z; Zhu T; Liu DX; Lobie PE Mol Cancer Ther; 2010 Jun; 9(6):1697-708. PubMed ID: 20530713 [TBL] [Abstract][Full Text] [Related]
9. Trefoil factor 3 is oncogenic and mediates anti-estrogen resistance in human mammary carcinoma. Kannan N; Kang J; Kong X; Tang J; Perry JK; Mohankumar KM; Miller LD; Liu ET; Mertani HC; Zhu T; Grandison PM; Liu DX; Lobie PE Neoplasia; 2010 Dec; 12(12):1041-53. PubMed ID: 21170268 [TBL] [Abstract][Full Text] [Related]
10. Artemin stimulates oncogenicity and invasiveness of human endometrial carcinoma cells. Pandey V; Qian PX; Kang J; Perry JK; Mitchell MD; Yin Z; Wu ZS; Liu DX; Zhu T; Lobie PE Endocrinology; 2010 Mar; 151(3):909-20. PubMed ID: 20118197 [TBL] [Abstract][Full Text] [Related]
11. High SRC-1 and Twist1 expression predicts poor prognosis and promotes migration and invasion by inducing epithelial-mesenchymal transition in human nasopharyngeal carcinoma. Zhou J; Zhang J; Xu M; Ke Z; Zhang W; Mai J PLoS One; 2019; 14(4):e0215299. PubMed ID: 30973923 [TBL] [Abstract][Full Text] [Related]
12. Twist1 promotes breast cancer invasion and metastasis by silencing Foxa1 expression. Xu Y; Qin L; Sun T; Wu H; He T; Yang Z; Mo Q; Liao L; Xu J Oncogene; 2017 Feb; 36(8):1157-1166. PubMed ID: 27524420 [TBL] [Abstract][Full Text] [Related]
13. Artemin is hypoxia responsive and promotes oncogenicity and increased tumor initiating capacity in hepatocellular carcinoma. Zhang M; Zhang W; Wu Z; Liu S; Sun L; Zhong Y; Zhang X; Kong X; Qian P; Zhang H; Lobie PE; Zhu T Oncotarget; 2016 Jan; 7(3):3267-82. PubMed ID: 26675549 [TBL] [Abstract][Full Text] [Related]
14. Akt/PKB-mediated phosphorylation of Twist1 promotes tumor metastasis via mediating cross-talk between PI3K/Akt and TGF-β signaling axes. Xue G; Restuccia DF; Lan Q; Hynx D; Dirnhofer S; Hess D; Rüegg C; Hemmings BA Cancer Discov; 2012 Mar; 2(3):248-59. PubMed ID: 22585995 [TBL] [Abstract][Full Text] [Related]
15. Prognostic significance of the expression of GFRα1, GFRα3 and syndecan-3, proteins binding ARTEMIN, in mammary carcinoma. Wu ZS; Pandey V; Wu WY; Ye S; Zhu T; Lobie PE BMC Cancer; 2013 Jan; 13():34. PubMed ID: 23351331 [TBL] [Abstract][Full Text] [Related]
16. Over-Expressed Twist Associates with Markers of Epithelial Mesenchymal Transition and Predicts Poor Prognosis in Breast Cancers via ERK and Akt Activation. Zhang YQ; Wei XL; Liang YK; Chen WL; Zhang F; Bai JW; Qiu SQ; Du CW; Huang WH; Zhang GJ PLoS One; 2015; 10(8):e0135851. PubMed ID: 26295469 [TBL] [Abstract][Full Text] [Related]
17. A Novel Oxoglutarate Dehydrogenase-Like Mediated miR-214/TWIST1 Negative Feedback Loop Inhibits Pancreatic Cancer Growth and Metastasis. Liu Y; Meng F; Wang J; Liu M; Yang G; Song R; Zheng T; Liang Y; Zhang S; Yin D; Wang J; Yang H; Pan S; Sun B; Han J; Sun J; Lan Y; Wang Y; Liu X; Zhu M; Cui Y; Zhang B; Wu D; Liang S; Liu Y; Song X; Lu Z; Yang J; Li M; Liu L Clin Cancer Res; 2019 Sep; 25(17):5407-5421. PubMed ID: 31175094 [TBL] [Abstract][Full Text] [Related]
18. Gene expression in extratumoral microenvironment predicts clinical outcome in breast cancer patients. Román-Pérez E; Casbas-Hernández P; Pirone JR; Rein J; Carey LA; Lubet RA; Mani SA; Amos KD; Troester MA Breast Cancer Res; 2012 Mar; 14(2):R51. PubMed ID: 22429463 [TBL] [Abstract][Full Text] [Related]
19. miR-720 inhibits tumor invasion and migration in breast cancer by targeting TWIST1. Li LZ; Zhang CZ; Liu LL; Yi C; Lu SX; Zhou X; Zhang ZJ; Peng YH; Yang YZ; Yun JP Carcinogenesis; 2014 Feb; 35(2):469-78. PubMed ID: 24085799 [TBL] [Abstract][Full Text] [Related]
20. α-Parvin promotes breast cancer progression and metastasis through interaction with G3BP2 and regulation of TWIST1 signaling. Sun Y; Ding Y; Guo C; Liu C; Ma P; Ma S; Wang Z; Liu J; Qian T; Ma L; Deng Y; Wu C Oncogene; 2019 Jun; 38(24):4856-4874. PubMed ID: 30804457 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]